Israel Active

Israel’s KeepMed is currently conducting clinical trials of its KeePAP device to help patients with Obstructive Sleep Apnea (OSA) open their airways and reduce snoring. The soft, lightweight, hose-less wearable is designed for comfort and to restore good-quality sleep.

Tel Aviv’s Sourasky (Ichilov ) medical center is implementing the advanced AI surgical intelligence platform from US-Israel’s Theator (reported previously). It extracts and annotates every key moment from a procedure to allow surgeons to review their work from every angle.

The student projects exhibited at Israel’s Technion Faculty of Biomedical Engineering included systems for predicting epileptic seizures, mood tracking in cancer patients, and prevention of sudden death in athletes. First prize went to Lidan Fridman for her new technology to diagnose hearing loss accurately.

Scientists at Israel’s Technion Institute have uncovered the atomic structure of Antimicrobial peptides (AMPs) in the immune system. It could lead to the design of similar artificial materials for technological and medical applications such as treating infections and even killing cancer cells.

Israel’s SURE Universal and UAE’s Hamad Bin Khalifa (HBK) have launched HBKiCare - the first joint UAE-Israeli tech product. The homecare kit monitors temperature, ECG, pulse, blood oxygen, blood pressure and detect falls. It is marketed for the UAE and Middle East markets.

Medical professionals from Israel and the UAE attended the JLM-BioCity sponsored IGTCloud Online Conference, “How Big Data & AI Can Fight the COVID-19 Crisis”.  UAE and Israeli medical experts then presented sessions in a webinar on the UAE Healthcare sector.

Israel’s Medasense assesses levels of pain in non-communicative patients using its PMD200 pain monitoring device. The technology is now being advanced on ventilated COVID-19 patients. Medtronic is distributing the tech in Europe and FDA approval is in progress.

Haifa’s Rambam hospital has opened its fortified underground emergency hospital to accommodate the rise in Covid-19 patients in Northern Israel.  Its 770 beds include 170 for patients on ventilators – sufficient for almost the total of Covid-19 patients currently hospitalized in Israel.

This newsletter previously featured the coronavirus sanitation bridging tunnel developed by Israel’s RD PACK. The video describes its key component - the disinfectant spray – comprised, amazingly, of electrolyzed water (no chemicals) developed at Israel’s Bar-Ilan University.

Scientists at Israel’s Weizmann Institute have discovered that bacteria contain viperins – enzymes that produce antiviral molecules.  These substances are undergoing testing that may lead to the development of highly effective antiviral treatments against influenza and COVID-19.